GI
LKFT

GAMMA Investing’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

GAMMA Investing’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6K Sell
954
-1,051
-52% -$29.8K ﹤0.01% 2647
2026
Q1 		$60.1K Buy
2,005
+755
+60% +$25K ﹤0.01% 2063
2025
Q4 		$40.9K Sell
1,250
-223
-15% -$7.2K ﹤0.01% 2201
2025
Q3 		$51K Buy
1,473
+652
+79% +$20.9K ﹤0.01% 1977
2025
Q2 		$23K Buy
821
+417
+103% +$11.2K ﹤0.01% 2384
2025
Q1 		$10.1K Sell
404
-1,829
-82% -$46.2K ﹤0.01% 2738
2024
Q4 		$61.4K Buy
2,233
+974
+77% +$27.2K 0.01% 1497
2024
Q3 		$36.2K Buy
1,259
+736
+141% +$20K ﹤0.01% 1717
2024
Q2 		$13K Sell
523
-252
-33% -$7.15K ﹤0.01% 2100
2024
Q1 		$25K Sell
775
-386
-33% -$14.4K 0.01% 1487
2023
Q4 		$43.6K Buy
+1,161
New +$42.7K 0.01% 973

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $306M AUM 40.46% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

GAMMA Investing's LKFT Position: Q2 2026 in Review

GAMMA Investing reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 52% in Q2 2026, selling an estimated $29.8K and leaving 954 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2647.

GAMMA Investing first reported a position in LKFT in Q4 2023 and has held it in 11 quarters since. The position peaked at $61.4K in Q4 2024. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • GAMMA Investing held 954 shares of Lakefront Biotherapeutics American Depositary Shares worth $28.6K as of Q2 2026.
  • GAMMA Investing sold 1,051 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $29.8K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2647 holding.
  • GAMMA Investing first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Lakefront Biotherapeutics American Depositary Shares position peaked at $61.4K in Q4 2024.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.